NCT00996008View on ClinicalTrials.gov

CT 327 in the Treatment of Atopic Dermatitis

PHASE2TerminatedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
Mild to Moderate Atopic Dermatitis
Interventions
DRUG

placebo

0.5 g (w/w) placebo cream applied to each target lesion twice daily

DRUG

CT 327

0.5 g CT 327 cream will be applied to 2 target lesions twice daily 0.5 g placebo cream will be applied to remaining 2 target lesions twice daily

Trial Locations (5)

4031

University Hospital, Basel

CH-3010

Inselspital, Bern

CH-1011

CHUV, Hôpital de Beaumont, Lausanne

CH-9007

Kantonsspital St Gallen, Sankt Gallen

CH-8091

University Hospital, Zurich

Sponsors

Lead Sponsor

Creabilis SA
All Listed Sponsors
lead

Creabilis SA

INDUSTRY